Browse Cancer vaccines topic

Product development subtopic

Articles 1-50 out of 50 article(s) Title Author Type Date Words Geron Presents Interim Clinical Data on Its Telomerase Vaccine at the 2009 American Society of Hematology Meeting. Dec 8, 2009 1264 Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL-7) in Patients with High Risk Pediatric Solid Tumors. Nov 23, 2009 1136 Synexus Set to Target Cancer Vaccine Trials. Oct 7, 2009 369 Updated Advaxis Phase I Survival Data Indicates Long-Term Immune Protection. Oct 1, 2009 671 Pancreatic and Colorectal Cancer Novel Antibody Developed from a Vaccine to Begin Phase I Trial. Sep 17, 2009 423 Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate. Sep 14, 2009 960 Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics' Oncophage[R] Cancer Vaccine in Newly Diagnosed Glioma. Aug 12, 2009 829 United States : Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics Oncophage[R] Cancer Vaccine in Newly Diagnosed Glioma. Aug 12, 2009 254 Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer. Jun 22, 2009 1112 Shot in the arm: ImmunoCellular Therapeutic Ltd. Mendoza, Lauren Alicia Brief article Mar 23, 2009 34 Idera Pharmaceuticals Scientists Co-Author Paper on Preclinical Data of Investigational Cancer Vaccine. Mar 4, 2009 633 Cyto Pulse, the Karolinska Institute and Uppsala University Hospital Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Using a Xenogenic PSA DNA Vaccine. Oct 10, 2008 360 Biovest Announces BiovaxID(R) Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44%. Oct 7, 2008 2298 Vaccine prevents prostate cancer in mice. McBride, Deborah Brief article Sep 1, 2008 277 Inovio Biomedical Provides Updated Interim Data on Phase I/II Clinical Study of Electroporation-Delivered Prostate Cancer DNA Vaccine at ASGT Annual Meeting. Jun 5, 2008 1020 Juvaris BioTherapeutics Initiates Phase 1 Clinical Trial of JVRS-100 Adjuvanted Seasonal Influenza Vaccine. May 28, 2008 712 Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer. Apr 16, 2008 1701 Ichor Melanoma Vaccine Clinical Trial Moves to Highest Dose Level. Mar 4, 2008 602 Geron Receives Milestone Payment from Merck Triggered by IND Filing for Telomerase Cancer Vaccine Candidate. Dec 12, 2007 551 Sidney Kimmel readies breast cancer vaccine for human testing: immunotherapy approach considered 'controversial'. Chambers, Heather Dec 3, 2007 700 Accentia Biopharmaceuticals Announces Unblinding and Analysis of Fast Tracked Phase 3 Trial for BiovaxID. Oct 16, 2007 1184 Advaxis' John Rothman to Present Phase I Data at the World Vaccine Congress 2007. Oct 4, 2007 521 'Magic bullet' free to first 60 cancer patients; Drug company set to carry out clinical trials. Sep 6, 2007 552 Nanotherapeutics and the Vaccine Branch of the National Cancer Institute Enter Into Cooperative Research and Development Agreement (CRADA). Aug 7, 2007 482 Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia. Jul 11, 2007 1129 Goodwin Biotechnology and Menarini Announce the Successful Completion of Their Strategic US-Italian Cooperation to Fight Ovarian Cancer. Jul 10, 2007 585 Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma. Jun 28, 2007 1111 Interim Analysis of Anti-Cancer Vaccine, BiovaxID, to be Conducted. Jun 13, 2007 1366 Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest, Receives Request From the Independent Data Monitoring Committee to Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID. Jun 13, 2007 1366 Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine. Clinical report May 22, 2007 1290 Inovio Biomedical Partner Tripep Provides Update on its Hepatitis C DNA Vaccine Program. May 21, 2007 853 Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials. May 17, 2007 1032 FDA Approves Phase I Clinical Trial Using Ichor's TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering. May 14, 2007 738 Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial. Apr 17, 2007 686 Venture Research Institute (VRI) Announces Plans for FDA Anti-cancer Vaccine Trials. Apr 11, 2007 570 SLOAN CANCER VACCINE PHASE III STUDY BEGINS. Apr 1, 2007 651 Cytogen Announces Initiation of NCI-Sponsored Phase 2 Clinical Trial of QUADRAMET with Targeted Cancer Vaccine for Hormone-Refractory Prostate Cancer. Clinical report Mar 1, 2007 1576 Advaxis Partners with Gynecologic Oncology Group for Phase II Study of Company's Lead Cervical Cancer Vaccine. Dec 19, 2006 845 Advaxis Completes Dosing and Enrollment of First Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial. Nov 7, 2006 659 Biovest International's Phase 3 Therapy for Follicular Lymphoma Receives Independent Support From Newly Published Phase 2 Trial Data. Oct 19, 2006 807 Experts Available to Discuss Cervical Cancer Treatment, Prevention. Jun 13, 2006 1040 FDA Advisory Committee Votes Unanimously That Clinical Data Support the Efficacy and Safety of GARDASIL(R), Merck's Investigational Cervical Cancer Vaccine; If Approved, GARDASIL Will Be the First Cervical Cancer Vaccine in the U.S. May 18, 2006 1582 MGI PHARMA EXPECTS $78 MILLION TOTAL REVENUE FOR FIRST QTR. May 1, 2006 485 In the Therapeutic Vaccine Industry, Cancer Vaccines Accounted for 60.6% of Projects Being Developed. Feb 14, 2006 370 Accentia Biopharmaceuticals Announces That Follow-up Data from the Phase II Clinical Trial of BiovaxID(TM) Will Be Presented at the Annual Meeting of the American Society for Hematology. Dec 1, 2005 826 Bavarian Nordic announces further investment in smallpox vaccine production and product development in the United States and Europe. Feb 1, 2005 661 Potential cervical cancer vaccine. Dec 1, 2004 119 Failed skin cancer tests prompts maxim stock drop: shareholders file class action suit. Webb, Marion Sep 27, 2004 708 CancerVax gets FDA OK. (Week in Review). Brief Article Apr 21, 2003 189 CytRx forms prostate cancer alliance with Cytogen and Progenics. Jan 1, 2003 966